KAYS · Kaya Holdings, Inc.
Market Cap
$68,644
Shares
686.44M
KAYS metrics
50 of 114 screener metrics currently available.
Market overview
2 metricsShare price
$0.00
Market cap
$68,644
Price action
19 metricsPrice change (1W)
+0.0%
Price change (30D)
+0.0%
Price change (3M)
-98.8%
Price change (6M)
-99.7%
Price change (YTD)
-99.7%
Price change (1Y)
-99.3%
Trailing year
Price change (5Y)
-99.9%
52-week high
$0.06
52-week low
$0.00
Change from 52-week high
-99.8%
Change from 52-week low
+0.0%
Annualized volatility
576.2%
Beta
-1.7
RSI (14D)
36.9
Price vs SMA 50
-99.3%
Price vs SMA 200
-99.7%
Avg volume (3M)
9,077
Relative volume
1.5
Average dollar volume
$87
Company
3 metricsSector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Shares outstanding
686.44M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
2.6×
reciprocal yield 38.9%
P / book
—
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-17,106.5%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
—
Profitability
9 metricsGross margin
-5.1%
Operating margin
-28,343.5%
Trailing 12 months
Net margin
-29,168.2%
Gross profit (TTM)
—
Operating profit (TTM)
−$1.14M
Net income (TTM)
−$11.74M
Trailing 12 months
Diluted EPS (TTM)
$-0.12
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
+80.3%
Year over year
Net income growth YoY
-229.3%
Revenue (TTM)
$26,691
Trailing 12 months
EPS growth YoY
-800.0%
Shares change YoY
+507.6%
Year over year · more shares
Revenue CAGR (3Y)
-80.0%
Revenue CAGR (5Y)
-62.9%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
—
Return on assets
-5,890.2%
Debt / equity
—
Current ratio
0.0
EBITDA (TTM)
−$1.13M
Free cash flow (TTM)
—
Quick ratio
0.0
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$26,087
Total assets
$199,358
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$786,140
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$684,750
R&D / revenue
—
Stock compensation / revenue
—
Ownership (13F)
3 metrics13F filers
0
13F filer change QoQ
-1
Institutional ownership
—
Short interest
3 metricsShort interest
—
Latest settlement
Days to cover
—
Short-squeeze score
—
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—